2269 — WuXi Biologics (Cayman) Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapHigh Flyer

Annual balance sheet for WuXi Biologics (Cayman), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	8,481	11,126	8,714	11,243	10,710
Net Total Accounts Receivable
Net Total Receivables	3,122	4,851	6,126	6,783	6,458
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	14,204	19,530	18,470	21,198	23,573
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12,870	19,756	25,916	29,939	28,435
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	28,964	44,033	49,564	56,576	56,977
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4,498	8,256	9,319	7,636	8,621
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	8,399	11,754	14,517	16,244	15,158
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	20,564	32,279	35,047	40,332	41,819
Total Liabilities & Shareholders' Equity	28,964	44,033	49,564	56,576	56,977
Total Common Shares Outstanding